Showing results (1-10 of 659) with videos related to
Sort By:
Pageof 66
Journal of Cardiology|September 21, 2014
Roadmap to inpatient heart failure managementMuthiah Vaduganathan, Mihai GheorghiadeEuropean Heart Journal Supplements : Journal of the European Society of Cardiology|December 22, 2022
A rationale for dedicated trials of combination therapy in heart failureVanessa Blumer, Muthiah VaduganathanJACC. Heart Failure|February 2, 2019
Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for CardiologistsOrly Vardeny, Muthiah VaduganathanCurrent Opinion in Cardiology|July 11, 2020
Targeting multiple domains of residual cardiovascular disease risk in patients with diabetesKershaw V Patel, Muthiah VaduganathanProceedings (Baylor University. Medical Center)|July 2, 2014
Sudden flare of rheumatoid arthritis associated with newly diagnosed atrial flutterMuthiah Vaduganathan, Joel N AuslanderClinical Cardiology|July 5, 2022
Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fractionJohn W Ostrominski, Muthiah VaduganathanHeart Failure Clinics|July 2, 2013
Epidemiology of hospitalized heart failure: differences and similarities between patients with reduced versus preserved ejection fractionMuthiah Vaduganathan, Gregg C FonarowThe American Journal of Medicine|May 9, 2023
Chapter 2: Clinical and Mechanistic Potential of Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors in Heart Failure with Preserved Ejection FractionJohn W Ostrominski, Muthiah VaduganathanCurrent Diabetes Reports|October 11, 2020
What Makes Sodium-Glucose Co-Transporter-2 Inhibitors Stand out in Heart Failure?Muhammad Shahzeb Khan, Muthiah VaduganathanCurrent Cardiology Reports|October 18, 2016
Angiotensin-Neprilysin Inhibition as a Paradigm for All?Muthiah Vaduganathan, Akshay S DesaiPageof 66